Skip to main content
Livermore
Livermore
ZHEN

LSV Asset Management

SEC CIK
0001050470
Latest filing
Aug 6, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by LSV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q2 2026)
197,300
Value
$3.42M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of AMRX by LSV Asset Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026197,300$3.42M<0.1%00.0%UnchangedHolders
Q1 2026197,300$2.45M<0.1%00.0%UnchangedHolders
Q4 2025197,300$2.49M<0.1%00.0%UnchangedHolders
Q3 2025197,300$1.98M<0.1%+27,400+16.1%AddedHolders
Q2 2025169,900$1.37M<0.1%00.0%UnchangedHolders
Q1 2025169,900$1.42M<0.1%+169,900NewHolders
Q3 20240$00.0%−1,057,300−100.0%Sold outHolders
Q2 20241,057,300$6.71M<0.1%−8,300−0.8%ReducedHolders
Q1 20241,065,600$6.46M<0.1%−23,700−2.2%ReducedHolders
Q4 20231,089,300$6.61M<0.1%−340,000−23.8%ReducedHolders
Q3 20231,429,300$6.03M<0.1%+136,100+10.5%AddedHolders
Q2 20231,293,200$4.01M<0.1%−104,000−7.4%ReducedHolders
Q1 20231,397,200$1.94M<0.1%00.0%UnchangedHolders
Q4 20221,397,200$2.78M<0.1%00.0%UnchangedHolders
Q3 20221,397,200$2.82M<0.1%−135,000−8.8%ReducedHolders
Q2 20221,532,200$4.87M<0.1%−20,000−1.3%ReducedHolders
Q1 20221,552,200$6.47M<0.1%−19,000−1.2%ReducedHolders
Q4 20211,571,200$7.53M<0.1%+25,600+1.7%AddedHolders
Q3 20211,545,600$8.25M<0.1%00.0%UnchangedHolders
Q2 20211,545,600$7.91M<0.1%+282,000+22.3%AddedHolders
Q1 20211,263,600$8.50M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.